NON ALCOHOLIC FATTY LIVER DISEASE

More in NON ALCOHOLIC FATTY LIVER DISEASE

• World Liver Day: Impact of salt/sugar on liver health & NAFLD

  It is estimated that nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder, affecting 25.24 per cent of the general adult population and 59.67 per cent of diabetic patients worldwide, as per a study published in the peer-reviewed Current Pharmaceutical Design medical journal. To get a sense of what experts have to say about the role played by excessive salt and sugar intake in NAFLD, ETHealthworld, on the occasion of World Liver Day, spoke with medical specialists, who addressed some of the most frequently asked questions surrounding the disease.

  • Exclusive

  

• World Liver Day: Impact of salt/sugar on liver health & NAFLD

  It is estimated that nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder, affecting 25.24 per cent of the general adult population and 59.67 per cent of diabetic patients worldwide, as per a study published in the peer-reviewed Current Pharmaceutical Design medical journal. To get a sense of what experts have to say about the role played by excessive salt and sugar intake in NAFLD, ETHealthworld, on the occasion of World Liver Day, spoke with medical specialists, who addressed some of the most frequently asked questions surrounding the disease.

  • Exclusive

  

• Stringent check needed on escalating burden of Non-Alcoholic Fatty Liver Disease: Dr Vivek Vij

  On the occasion of World Liver Day check out ETHealthworld's exclusive interaction with Dr Vivek Vij, Chairman, Liver Transplant, Hepato-Pancreato-Biliary Surgery, Fortis Escorts giving insights into changing trends in liver transplantation

  • Exclusive

  

• Non-heavy alcohol use associated with liver fibrosis: Study

  While evidence suggests that the pattern of alcohol consumption may be an important predictor of its health effects, alcohol research frequently focuses on average daily or weekly alcohol consumption, possibly obscuring differences in drinking patterns such as drinking frequency, the usual quantity of alcohol consumed and binge drinking behaviour.

  

• CMFRI comes up with natural remedy for fatty liver disease from seaweeds

  This is the ninth such product from marine organisms being developed by the CMFRI which already has brought out nutraceuticals to combat a series of lifestyle diseases, such as type-2 diabetes, arthritis, cholesterol, hypertension, hypothyroidism and osteoporosis, and to improve immunity.

  

• Why early detection of fatty liver is important

  Fatty liver and obesity are two intertwined health issues. They are also linked to a host of other non-communicable diseases, like heart and kidney disease and cancers. TOI is running a month-long campaign “Follow Your Gut”, a conversational series of four videos with Sharma. The first of the series was on GERD and the second on the “Role of Probiotics and Gluten Intolerance”. The third session talked about gastric cancer and non-invasive procedures. In the fourth and the last session, the US-based gastroenterologist highlighted key issues linked to fatty liver and obesity.

  

• Tackling Fatty Liver May Help Up Your Guard Against Most Diseases

  Excessive fat accumulated in the liver can also spill in the blood, leading to higher levels of cholesterol and triglyceride that are known risk factors for heart disease. Fat can also travel to the arteries, leading to atherosclerosis, heart disease and stroke.

  

• How excess sugar consumption causes fatty liver

  NAFLD is a condition in which excess fat deposits in the liver. The disease starts silently, with no overt symptoms for as much as two decades.

  

• Operational guidelines launched for integration of Non-Alcoholic Fatty Liver Disease with NPCDCS

  "Over the last two decades global burden of NASH has more than doubled. Globally, NASH caused 40 lakh prevalent cases of compensated cirrhosis in 1990, which increased to 94 lakh cases in 2017. NAFLD is emerging as an important cause of liver disease in India," Vardhan was quoted as saying in a Health Ministry statement.

  

• Study explains how a fat cell's immune response makes obesity worse

  The study was led by scientists at Cincinnati Children's and the University of Cincinnati College of Medicine and was published in Nature Communications.

  

• Zydus Cadila gets DCGI nod for world's first drug to treat liver disease

  Pharmaceutical major Zydus Cadila on Thurday said it has received Drug Controller General of India (DCGI) approval for its new drug application for Saroglitazar to treat a particular condition of liver, commonly known as NASH in India.